×

You are using a browser that is no longer supported for this website.
Please use the latest version of Chrome, Firefox, Edge or Safari.

Subpulmonary support for your patients with failing Fontan circulatory

Patients with Fontan circulatory failure suffer from many Fontan associated end-organ dysfunctions like chronic liver congestion, plastic bronchitis, or protein losing enteropathy and urgently need a donor heart. While these comorbidities indicate a heart transplantation, at the same time they worsen its chance of success.

The EXCOR® Venous Cannula is designed to offer a standardized implantation of the EXCOR® VAD to support the subpulmonary circulation of these patients. The EXCOR® Venous Cannula can either be used alone or in a biventricular configuration to ensure subpulmonary and systemic support. 

This support aims to improve the patient‘s health status. An improvement of end-organ 
function and hemodynamics lead to better chances on the waiting list.

Benefits

The EXCOR® Venous Cannula is designed to...

 

                        ► improve subpulmonary hemodynamics,

                        ► reduce mortality and morbidity on the waiting list,

                        ► reduce the complexity of the surgery,

                        ► improve end-organ function.

“These patients often have adequate function of their ventricle but extremely poor circulation due to this unphysiological flow pattern after Fontan surgery. In this situation, artificial sub-pulmonary support is the only way to normalize hemodynamics, allow for organ recovery during mechanical support therapy and consequently has the potential to lower mortality and morbidity on the waiting list. Moreover, we are confident that we can reduce the risk of the heart transplantation in failing Fontan hemodynamics.” 

Prof. Dr. Nikolaus Haas, LMU University Hospital Munich, Germany,

“This specially designed cannula could lead to a significant shortening of operation time and due to flow optimization to a decreased risk for thromboembolic events.”

Dr. Eugen Sandica, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany

“The venous cannula offers a standardized implantation of the EXCOR® device for support of the subpulmonary circulation in Fontan patients.” 

Prof. Dr. Daniel Zimpfer, Medical University of Vienna, Austria

“RVAD or BVAD support can normalize hemodynamics, allow for organ recovery during mechanical support and consequently has the potential to lower mortality and morbidity on the waiting list.”

 Prof. Dr. med. Stanislav Ovroutski, German Heart Institute Berlin

The EXCOR® Venous Cannula
enables you to build a bridge to transplant for your patients
with failing Fontan circulation.   

Technical Data

Optimal fitting to the anatomy of your patient with 3 different models

Indicated for RVAD and BVAD patients with a BSA ≥ 1.2 m².

 

Contact

 

For more information regarding approval and availability in your region, please contact us here.

The access to some or all shown products may be restricted by country-specific regulatory approvals. The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Excor mobile and EXCOR® Active is not FDA approved and not available for commercial use in the US. The configuration of the EXCOR® Arterial Cannula for Graft as shown in Figure 1 has not yet been CE marked.